Radiology solutions company Imaging Endpoints launches new research subsidiary

Imaging Endpoints, a clinical trial-focused radiology company, has launched a new research subsidiary, the firm announced Wednesday.

Scottsdale, Arizona-based Imaging Endpoints said the new wholly-owned Research Endpoints will manage the growing demand for its exploratory imaging research and biomarker discovery business.

With more than 100 physicians across the U.S., including 40 in-house radiologists, the firm supports imaging research with services that include textural analysis, radiomics and artificial intelligence.

Imaging Endpoints and its new sister company will both share the same executive leadership team and scientific advisory board. The latter includes renowned Johns Hopkins Radiology Professor Elliot K. Fishman, MD, who was appointed back in January.

"The formation of Research Endpoints is yet another example of our desire to ensure that our sponsors, partners, investigators, and patients continue to benefit from our industry-leading science and analytics,” Chief Medical Officer Ron Korn, MD, PhD, said in a statement.

Imaging Endpoints is an affiliate of Scottsdale-based HonorHealth, which operates some 70 primary and specialty care clinics along with six hospitals, according to its website. IE is also affiliated with Southwest Medical Imaging, one of the largest private radiology groups in the U.S.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.